Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
Pharmacological Reviews|September 27, 2015
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for DiseaseChristopher L German, Michelle G Baladi, Lisa M McFadden, et al.
Synapse (New York, N.Y.)|November 21, 2008
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicityTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2010
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activationGregory C Hadlock, Pei-Wen Chu, Elliot T Walters, et al.
Synapse (New York, N.Y.)|August 27, 2014
Mephedrone alters basal ganglia and limbic dynorphin systemsChristopher L German, Mario E Alburges, Amanda J Hoonakker, et al.
Behavioural Pharmacology|February 13, 2016
Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptorsMichelle G Baladi, Shannon M Nielsen, J Michael McIntosh, et al.
European Journal of Pharmacology|February 1, 2002
Tolerance to the neurotoxic effects of methamphetamine in young ratsEvan L Riddle, Jerry M Kokoshka, Diana G Wilkins, et al.
European Journal of Pharmacology|July 23, 2003
Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptorsYvette V Ugarte, Kristi S Rau, Evan L Riddle, et al.
European Journal of Pharmacology|April 2, 2014
Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermiaMichelle G Baladi, Amy H Newman, Shannon M Nielsen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 6, 2013
Age-related differences in the disposition of nicotine and metabolites in rat brain and plasmaPaula L Vieira-Brock, David M Andrenyak, Shannon M Nielsen, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
Pharmacological Reviews|September 27, 2015
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for DiseaseChristopher L German, Michelle G Baladi, Lisa M McFadden, et al.
Synapse (New York, N.Y.)|November 21, 2008
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicityTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2010
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activationGregory C Hadlock, Pei-Wen Chu, Elliot T Walters, et al.
Synapse (New York, N.Y.)|August 27, 2014
Mephedrone alters basal ganglia and limbic dynorphin systemsChristopher L German, Mario E Alburges, Amanda J Hoonakker, et al.
Behavioural Pharmacology|February 13, 2016
Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptorsMichelle G Baladi, Shannon M Nielsen, J Michael McIntosh, et al.
European Journal of Pharmacology|February 1, 2002
Tolerance to the neurotoxic effects of methamphetamine in young ratsEvan L Riddle, Jerry M Kokoshka, Diana G Wilkins, et al.
European Journal of Pharmacology|July 23, 2003
Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptorsYvette V Ugarte, Kristi S Rau, Evan L Riddle, et al.
European Journal of Pharmacology|April 2, 2014
Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermiaMichelle G Baladi, Amy H Newman, Shannon M Nielsen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 6, 2013
Age-related differences in the disposition of nicotine and metabolites in rat brain and plasmaPaula L Vieira-Brock, David M Andrenyak, Shannon M Nielsen, et al.
Pageof 8